TILDIEM

This brand name is authorized in France, Italy, Netherlands, Tunisia, United Kingdom

Active ingredients

The drug TILDIEM contains one active pharmaceutical ingredient (API):

1 Diltiazem UNII OLH94387TE - DILTIAZEM HYDROCHLORIDE

Diltiazem is a calcium antagonist. It restricts the slow channel entry of calcium into the cell and so reduces the liberation of calcium from stores in the sarcoplasmic reticulum. This results in a reduction of the amount of available intracellular calcium reducing myocardial oxygen consumption. Read about Diltiazem

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TILDIEM Modified-release tablets	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C08DB01	Diltiazem	C Cardiovascular system → C08 Calcium channel blockers → C08D Selective calcium channel blockers with direct cardiac effects → C08DB Benzothiazepine derivatives
Discover more medicines within C08DB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FR	Base de données publique des médicaments	Identifier(s): 60998977, 62018628, 63692245
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 18007, 18042, 18087, 18112, 18120, 196204, 196205, 196206, 374002, 374003, 377054, 377306, 380160, 381698, 381700, 393607, 398366
Country: IT	Agenzia del Farmaco	Identifier(s): 025278019, 025278058, 025278060, 025278072
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 40444, 40452
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 9043191